Form 4 for BSX Boston Scientific
Accepted 2024-04-02 00:00:00 ET · period of report 2024-04-01 · accession 0001225208-24-004849 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-02 | 2024-04-01 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $16.31 | +16.4K | 67.0K | +32% | +$266.7K |
| D | 2024-04-02 | 2024-04-01 | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale+OE | $69.30 | -16.4K | 50.6K | -24% | -$1.13M |
| D | 2024-04-02 | 2024-04-01 | BSX | Sorenson John Bradley | EVP, Gbl Ops | M - OptEx | $0.00 | -16.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | M | A | 16,351 | $16.31 | 66,989 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | S | D | 16,351 | $69.30 | 50,638 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $68.10 to 68.53, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-01 | M | D | 16,351 | $0.00 | 0 | D | $16.31 · — to 2025-02-23 | 16,351 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |